The deal was Novo Nordisk’s bid to grab back market share from the cheaper, knockoff versions that Hims & Hers and other ...

The Patients Deserve Price Tags Act, introduced by Sens. Roger Marshall and John Hickenlooper, would provide upfront price ...

Medical supply chain costs are expected to rise by 2.41% in 2026, according to Vizient’s Summer 2025 Spend Management Outlook, released July 29. The increase will be driven by rising costs in IT ...

Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest Pharmacy Market Outlet report, released in July. The report found that price pressures are easing in certain ...

About two years ago, celebrity cosmetic dermatologist Dr. Paul Jarrod Frank noticed a new type of patient arriving at his New York practice. Amid an explosion in the number of Americans losing weight ...

Longevity is—thankfully—on the rise across the country. But a longer life often means a higher chance of needing help down ...

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

A JAMA Network Open study reveals that patients with private insurance can face monthly costs nearing $600 after a cancer ...